NLRP3 and gout: The pathogenesis of gouty arthritis has also been correlated with IL-1β [7] via TNF-α [8], and NLRP3 inflammasome activation in macrophages [9] and chemokines [10] and an IL-1β antibody has been shown to provide superior inflammation prophylaxis than colchicine in patients with gout [11].